2.0
May 2, 2013
Anonymous employee
Current employee
Recommend
CEO approval
Business Outlook
Pros
Strong financial management and great product performance TODAY
Cons
lack of developmental opportunites Too much exposure to HUMIRA \ Can we get anything to lauch out of our pipeline? Conflicing directions -- be a lean, decisive biopharmaceutical company and yet we just signed a CIA